← All trials
NCT05328531
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 22, 2021
- Primary completion
- May 28, 2022
- Completion date
- May 28, 2022
- First posted
- Apr 14, 2022
- Last posted
- Apr 14, 2022
- Enrollment
- 121
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- GeneScience Pharmaceuticals Co., Ltd.Lead sponsor
- Changhai HospitalCollaborator
- Hainan People's HospitalCollaborator
- Linyi People's HospitalCollaborator
- Nanjing Medical UniversityCollaborator
- Shengjing HospitalCollaborator
- Chongqing Medical UniversityCollaborator
- Fudan UniversityCollaborator
- Fudan UniversityOverall official - principal investigator
- Fudan UniversityOverall official - principal investigator
- Nantong UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.